Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1971 2
1973 1
1978 3
1991 3
1994 2
1998 2
1999 1
2000 3
2001 4
2002 7
2003 12
2004 17
2005 19
2006 16
2007 19
2008 29
2009 14
2010 9
2011 17
2012 11
2013 9
2014 11
2015 3
2016 6
2017 10
2018 11
2019 7
2020 5
2021 2
2022 3
2023 1
2024 1
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

237 results

Results by year

Filters applied: . Clear all
Page 1
SAHRANG: Subarachnoid Hemorrhage Recovery and Galantamine: A Pilot Multicenter Randomized Placebo-Controlled Trial.
Yang BSK, Savarraj JPJ, Moreno E, Immanuel KE, Hergenroeder G, Torres G, Kim JH, Samuel S, Pedroza C, Grotta JC, Barreto A, Choi HA. Yang BSK, et al. Neurocrit Care. 2025 Dec;43(3):986-998. doi: 10.1007/s12028-025-02349-3. Epub 2025 Aug 28. Neurocrit Care. 2025. PMID: 40877496 Free PMC article. Clinical Trial.
We hypothesize that galantamine treatment after SAH mitigates inflammation-mediated neuronal injury and improve outcomes. ...The first 30 patients were randomly assigned to receive galantamine at 8 mg every 12 h or a placebo, and the other 30 patients to were random …
We hypothesize that galantamine treatment after SAH mitigates inflammation-mediated neuronal injury and improve outcomes. ...The firs …
Galantamine and Computerized Cognitive Behavioral Therapy for Cocaine Dependence: A Randomized Clinical Trial.
Carroll KM, Nich C, DeVito EE, Shi JM, Sofuoglu M. Carroll KM, et al. J Clin Psychiatry. 2018 Jan/Feb;79(1):17m11669. doi: 10.4088/JCP.17m11669. J Clin Psychiatry. 2018. PMID: 29286595 Free PMC article. Clinical Trial.
One hundred twenty individuals diagnosed with DSM-IV cocaine use disorder were randomly assigned to the following conditions: (1) galantamine (8 mg/d) plus standard methadone maintenance treatment (treatment as usual [TAU]), (2) placebo plus TAU, (3) galantamine plu …
One hundred twenty individuals diagnosed with DSM-IV cocaine use disorder were randomly assigned to the following conditions: (1) galanta …
A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.
Buchanan RW, Kelly DL, Weiner E, Gold JM, Strauss GP, Koola MM, McMahon RP, Carpenter WT. Buchanan RW, et al. J Clin Psychopharmacol. 2017 Aug;37(4):394-400. doi: 10.1097/JCP.0000000000000720. J Clin Psychopharmacol. 2017. PMID: 28590362 Free PMC article. Clinical Trial.
The MATRICS Consensus Cognitive Battery composite score was used to assess cognition (the primary outcome measure for galantamine). FINDINGS/RESULTS: There were no significant group differences for negative symptoms (oxytocin vs placebo: F2,47.4 = 0.19, P = 0.83; galant …
The MATRICS Consensus Cognitive Battery composite score was used to assess cognition (the primary outcome measure for galantamine). F …
The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease.
Rockwood K, Fay S, Gorman M. Rockwood K, et al. Int J Geriatr Psychiatry. 2010 Feb;25(2):191-201. doi: 10.1002/gps.2319. Int J Geriatr Psychiatry. 2010. PMID: 19548273 Clinical Trial.
In an investigator-initiated, clinical trial of galantamine, we investigated the extent to which a 4-point change classifies goal attainment by individual patients. METHODS: Secondary analysis of the video imaging synthesis of treating Alzheimer's disease (VISTA) study: a …
In an investigator-initiated, clinical trial of galantamine, we investigated the extent to which a 4-point change classifies goal att …
The clinical efficacy and safety of galantamine in the treatment of Alzheimer's disease.
Dengiz AN, Kershaw P. Dengiz AN, et al. CNS Spectr. 2004 May;9(5):377-92. doi: 10.1017/s1092852900009378. CNS Spectr. 2004. PMID: 15115951 Clinical Trial.
The safety and efficacy of galantamine has been demonstrated in multiple randomized, Phase III trials of >2,600 patients with mild-to-moderate AD. ...The dual mechanism of action may make galantamine a reasonable treatment option for both newly diagnosed patients …
The safety and efficacy of galantamine has been demonstrated in multiple randomized, Phase III trials of >2,600 patients with mild …
An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia.
Erkinjuntti T, Kurz A, Small GW, Bullock R, Lilienfeld S, Damaraju CV; GAL-INT-6 Study Group. Erkinjuntti T, et al. Clin Ther. 2003 Jun;25(6):1765-82. doi: 10.1016/s0149-2918(03)80168-6. Clin Ther. 2003. PMID: 12860497 Clinical Trial.
METHODS: This was an open-label extension of a 6-month double-blind study of galantamine. Patients who had been randomized to receive galantamine 24 mg/d or placebo in the double-blind phase were eligible to continue open-label treatment with galantamine 24 m …
METHODS: This was an open-label extension of a 6-month double-blind study of galantamine. Patients who had been randomized to receive …
Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.
Ghaleiha A, Ghyasvand M, Mohammadi MR, Farokhnia M, Yadegari N, Tabrizi M, Hajiaghaee R, Yekehtaz H, Akhondzadeh S. Ghaleiha A, et al. J Psychopharmacol. 2014 Jul;28(7):677-85. doi: 10.1177/0269881113508830. Epub 2013 Oct 15. J Psychopharmacol. 2014. PMID: 24132248 Clinical Trial.
The role of cholinergic abnormalities in autism was recently evidenced and there is a growing interest in cholinergic modulation, emerging for targeting autistic symptoms. Galantamine is an acetylcholinesterase inhibitor and an allosteric potentiator of nicotinic receptors …
The role of cholinergic abnormalities in autism was recently evidenced and there is a growing interest in cholinergic modulation, emerging f …
Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial).
Litvinenko IV, Odinak MM, Mogil'naya VI, Emelin AY. Litvinenko IV, et al. Neurosci Behav Physiol. 2008 Nov;38(9):937-45. doi: 10.1007/s11055-008-9077-3. Neurosci Behav Physiol. 2008. PMID: 18975103 Clinical Trial.
An open controlled trial of the use of galantamine at a maximum dose of 16 mg/day included 41 patients with Parkinson's disease with dementia randomized to a galantamine treatment group (21 patients) and a control group (20 patients). ...Galantamine treatment …
An open controlled trial of the use of galantamine at a maximum dose of 16 mg/day included 41 patients with Parkinson's disease with …
Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCI.
Leijenaar JF, Groeneveld GJ, Klaassen ES, Leeuwis AE, Scheltens P, Weinstein HC, van Gerven JMA, Barkhof F, van der Flier WM, Prins ND. Leijenaar JF, et al. Alzheimers Res Ther. 2020 Jan 7;12(1):10. doi: 10.1186/s13195-019-0567-z. Alzheimers Res Ther. 2020. PMID: 31910895 Free PMC article. Clinical Trial.
All patients received single doses of methylphenidate (10 mg), galantamine (16 mg), and placebo in random order on three separate study visits. We used the NeuroCart , a computerized test battery, to assess drug-sensitive cognitive effects. ...Methylphenidate was well tole …
All patients received single doses of methylphenidate (10 mg), galantamine (16 mg), and placebo in random order on three separate stu …
237 results